{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.5:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_000345.5",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "H",
            "alt": "Y",
            "position": "30"
          },
          "Description in input context": "c.89C>T (p.H30Y)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0005146"
  },
  "Experiment Method": [
    {
      "Assay Method": "NMR spectroscopy",
      "Material used": {
        "Material Source": "Recombinant a-synuclein protein",
        "Material Name": "N/A",
        "Description": "The experiments were conducted using recombinant a-synuclein protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.5:c.89C>T",
          "Conclusion": "No change in amyloid fibril structure",
          "Molecular Effect": "N/A",
          "Result Description": "The A30P mutation does not cause changes in the number, location, and overall arrangement of Î²-strands in amyloid fibrils."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": "N/A",
      "Basic positive control": "No",
      "Basic negative control": "N/A",
      "Validation controls P/LP": "N/A",
      "Validation controls B/LB": "N/A",
      "Statistical analysis method": "N/A",
      "Threshold for normal readout": "N/A",
      "Threshold for abnormal readout": "N/A",
      "Approved assay": "Yes"
    }
  ]
}